Landon Bruich

Role not yet determined Is this you? Add your title

UAMS

Also affiliated: University of Arkansas Medical Center (2025); Central Arkansas Veterans Healthcare System (2026)

1 h-index 18 pubs 1 cited

Research Areas

OverviewAI-generated summary

Landon Bruich's research focuses on cardiovascular outcomes and related health issues. His work includes examining the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention with or without a preceding coronary CT angiogram. He also investigates the real-world cardiovascular outcomes of combined SGLT2 inhibitor and GLP1 receptor agonist therapy in individuals with type 2 diabetes, as well as the outcomes of GLP-1RA therapy in obese non-diabetic patients with metabolic dysfunction-associated steatotic liver disease. Bruich's research also extends to the physiological and therapeutic potentials of sodium-glucose transport protein 2 inhibitors in cardiovascular and chronic kidney diseases, and the cardiovascular outcomes of specific therapies for hyperlipidemia. He has published on AI-enhanced ECG for acute coronary syndrome triage and the link between post-traumatic stress disorder and major cardiovascular outcomes. Bruich collaborates with several researchers at the University of Arkansas for Medical Sciences, including Robert Spraggins, Aakash Rana, Buthainah Alhwarat, and Subhi J. Al’Aref.

Metrics

h-index: 1
Publications: 18
Citations: 1

Selected Publications

AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review (2026)

Cardiovascular revascularization medicine DOI OpenAlex
Examining the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention with or without a preceding coronary CT angiogram (2026)

European Heart Journal - Imaging Methods and Practice 1 citation DOI OpenAlex
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)

Journal of the American College of Cardiology DOI OpenAlex
26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS (2026)

Journal of the American College of Cardiology DOI OpenAlex
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)

JACC: Cardiovascular Interventions DOI OpenAlex
Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis (2025)

Cureus DOI OpenAlex
In Search of Commonality: Physiological and Therapeutic Potentials of Sodium-Glucose Transport Protein 2 Inhibitors in Cardiovascular and Chronic Kidney Diseases (2025)

Cureus DOI OpenAlex
TCT-200 Association between the Occurrence of Coronary In-Stent Restenosis in Post-Renal Transplant Recipients and Adverse Cardiovascular Events (2025)

Journal of the American College of Cardiology DOI OpenAlex
TCT-415 Cardiovascular Outcomes in Individuals Undergoing Percutaneous Coronary Intervention with or without a Preceding Coronary CT Angiogram: A Comparison Using Real World Data (2025)

Journal of the American College of Cardiology DOI OpenAlex
TCT-262 Five-Year Mortality Comparison of Left Ventricular Unloading Devices for Individuals with Cardiogenic Shock on VA-ECMO (2025)

Journal of the American College of Cardiology DOI OpenAlex
Systemic Lupus Erythematosus Mimicking a Possible Eating Disorder (2025)

Cureus DOI OpenAlex
HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE (2025)

Journal of the American College of Cardiology DOI OpenAlex
SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2025)

Journal of the American College of Cardiology DOI OpenAlex
Successful Thrombolytic Therapy for Mechanical Mitral Valve Thrombosis Using Bivalirudin-Based Thrombolytic Regimen (2025)

JACC Case Reports DOI OpenAlex
BEYOND DIAGNOSIS: PROGNOSTIC UTILITY OF B-NATRIURETIC PEPTIDE IN PREGNANT PATIENTS PRESENTING TO ARKANSAS’ HIGH-RISK CARDIO-OBSTETRICS PROGRAM (2024)

American Journal of Preventive Cardiology DOI OpenAlex